tradingkey.logo

Helius Medical Technologies Inc

HSDT
2.780USD
-0.050-1.77%
收盤 12/26, 16:00美東報價延遲15分鐘
112.03M總市值
虧損本益比TTM

Helius Medical Technologies Inc

2.780
-0.050-1.77%

關於 Helius Medical Technologies Inc 公司

Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.

Helius Medical Technologies Inc簡介

公司代碼HSDT
公司名稱Helius Medical Technologies Inc
上市日期Jun 27, 2014
CEOAndreeff (Dane C)
員工數量21
證券類型Ordinary Share
年結日Jun 27
公司地址642 Newtown Yardley Road
城市NEWTOWN
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編18940
電話12159446100
網址https://heliusmedical.com/
公司代碼HSDT
上市日期Jun 27, 2014
CEOAndreeff (Dane C)

Helius Medical Technologies Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
15.00
-6.25%
Mr. Blane Walter
Mr. Blane Walter
Independent Director
Independent Director
2.00
-33.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
2.00
--
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Sherrie Perkins
Ms. Sherrie Perkins
Independent Director
Independent Director
--
--
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--
Mr. Dane C. Andreeff
Mr. Dane C. Andreeff
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Cosmo Jiang
Mr. Cosmo Jiang
Director
Director
--
--
Dr. Joseph Chee
Dr. Joseph Chee
Executive Chairman of the Board
Executive Chairman of the Board
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
15.00
-6.25%
Mr. Blane Walter
Mr. Blane Walter
Independent Director
Independent Director
2.00
-33.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
2.00
--
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Sherrie Perkins
Ms. Sherrie Perkins
Independent Director
Independent Director
--
--
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
Canada
26.00K
60.47%
Other revenue
10.00K
23.26%
United States
7.00K
16.28%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月20日 週四
更新時間: 11月20日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Fusion Summer Ltd
16.54%
Pantera Capital Partners LP
9.44%
Solana Rocket Holdings Ltd
9.41%
Polar Asset Management Partners Inc.
5.28%
Aristeia Capital, L.L.C.
2.64%
其他
56.70%
持股股東
持股股東
佔比
Fusion Summer Ltd
16.54%
Pantera Capital Partners LP
9.44%
Solana Rocket Holdings Ltd
9.41%
Polar Asset Management Partners Inc.
5.28%
Aristeia Capital, L.L.C.
2.64%
其他
56.70%
股東類型
持股股東
佔比
Corporation
25.96%
Hedge Fund
12.85%
Investment Advisor
9.87%
Investment Advisor/Hedge Fund
1.10%
Research Firm
0.06%
Individual Investor
0.02%
其他
50.14%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
24
3.90M
10.09%
+3.90M
2025Q2
37
12.45K
1.83%
+11.99K
2025Q1
40
16.72K
1.11%
-2.03K
2024Q4
43
261.97K
7.03%
-14.04K
2024Q3
43
183.78K
9.58%
-95.02K
2024Q2
46
285.33K
12.75%
+168.92K
2024Q1
47
120.01K
13.52%
+4.71K
2023Q4
50
81.05K
12.51%
-44.86K
2023Q3
52
56.40K
16.69%
-20.37K
2023Q2
56
42.39K
14.78%
-10.21K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Fusion Summer Ltd
6.83M
17.56%
+6.83M
--
Sep 18, 2025
Pantera Capital Partners LP
3.89M
9.99%
+3.89M
--
Sep 18, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
Jun 27, 2025
Merger
50→1
Apr 30, 2025
Merger
15→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
公告日期
類型
比率
Jun 27, 2025
Merger
50→1
Apr 30, 2025
Merger
15→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1

常見問題

Helius Medical Technologies Inc的前五大股東是誰?

Helius Medical Technologies Inc的前五大股東如下:
Fusion Summer Ltd
持有股份:6.83M
佔總股份比例:17.56%。
Pantera Capital Partners LP
持有股份:3.89M
佔總股份比例:9.99%。

Helius Medical Technologies Inc的前三大股東類型是什麼?

Helius Medical Technologies Inc 的前三大股東類型分別是:
Fusion Summer Ltd
Pantera Capital Partners LP
Solana Rocket Holdings Ltd

有多少機構持有Helius Medical Technologies Inc(HSDT)的股份?

截至2025Q3,共有24家機構持有Helius Medical Technologies Inc的股份,合計持有的股份價值約為3.90M,占公司總股份的10.09% 。與2025Q2相比,機構持股有所增加,增幅為8.26%。

哪個業務部門對Helius Medical Technologies Inc的收入貢獻最大?

在FY2025Q2,--業務部門對Helius Medical Technologies Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI